Literature DB >> 26790457

Exploring BAFF: its expression, receptors and contribution to the immunopathogenesis of Sjögren's syndrome.

Nicolyn Thompson1, David A Isenberg1, Elizabeth C Jury2, Coziana Ciurtin2.   

Abstract

SS is an autoimmune condition characterized by exocrine gland destruction, autoantibody production, immune complex deposition and systemic complications associated with lymphocytic infiltration of many organs. Genetic, environmental and viral factors play a role in disease aetiology, however, the exact mechanisms driving the immunopathogenesis of SS remain uncertain. Here we discuss a role for B cell activating factor (BAFF), whereby B cell hyperactivity and increased BAFF secretion observed in patients and animal models of the disease can be explained by the altered expression of cell-specific BAFF/BAFF receptor (BAFF-R) variants in several immune cell types. Understanding the role of BAFF/BAFF-R heterogeneity in SS pathogenesis could help to facilitate new treatment strategies for patients.
© The Author 2016. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  B cell activating factor (BAFF); BAFF receptor; Sjögren’s syndrome

Mesh:

Substances:

Year:  2016        PMID: 26790457     DOI: 10.1093/rheumatology/kev420

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  24 in total

1. 

Authors:  渊 任; 戈丹 崔; 永翔 高
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-12-25

Review 2.  Research progress on inflammatory mechanism of primary Sjögren syndrome.

Authors:  Yuan Ren; Gedan Cui; Yongxiang Gao
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-12-25

3.  Plasmacytoid dendritic cells promote the pathogenesis of Sjögren's syndrome.

Authors:  Jing Zhou; Xiaofeng Zhang; Qing Yu
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-11-12       Impact factor: 5.187

4.  High BAFF expression associated with active disease in systemic lupus erythematosus and relationship with rs9514828C>T polymorphism in TNFSF13B gene.

Authors:  M Marín-Rosales; A Cruz; D C Salazar-Camarena; E Santillán-López; N Espinoza-García; J F Muñoz-Valle; M G Ramírez-Dueñas; E Oregón-Romero; G Orozco-Barocio; C A Palafox-Sánchez
Journal:  Clin Exp Med       Date:  2019-02-11       Impact factor: 5.057

5.  TLR7 Signaling Drives the Development of Sjögren's Syndrome.

Authors:  Yawen Wang; Annie Roussel-Queval; Lionel Chasson; Noël Hanna Kazazian; Laetitia Marcadet; Andrianos Nezos; Michael H Sieweke; Clio Mavragani; Lena Alexopoulou
Journal:  Front Immunol       Date:  2021-05-24       Impact factor: 7.561

Review 6.  Lymphoma and Lymphomagenesis in Primary Sjögren's Syndrome.

Authors:  Alessia Alunno; Maria Comasia Leone; Roberto Giacomelli; Roberto Gerli; Francesco Carubbi
Journal:  Front Med (Lausanne)       Date:  2018-04-13

Review 7.  B Cell Activating Factor, Renal Allograft Antibody-Mediated Rejection, and Long-Term Outcome.

Authors:  Haiyan Xu; Xiaozhou He; Renfang Xu
Journal:  J Immunol Res       Date:  2018-06-06       Impact factor: 4.818

8.  Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm.

Authors:  Jun Luo; Yi Xie; Yuxiao Zheng; Chenji Wang; Feng Qi; Jiateng Hu; Yaoting Xu
Journal:  Cancer Med       Date:  2020-04-20       Impact factor: 4.452

Review 9.  Cell-Type Targeted NF-kappaB Inhibition for the Treatment of Inflammatory Diseases.

Authors:  Bettina Sehnert; Harald Burkhardt; Stefan Dübel; Reinhard E Voll
Journal:  Cells       Date:  2020-07-06       Impact factor: 6.600

10.  Differential long non-coding RNA expression profile and function analysis in primary Sjogren's syndrome.

Authors:  Xiaochan Chen; Qi Cheng; Yan Du; Lei Liu; Huaxiang Wu
Journal:  BMC Immunol       Date:  2021-07-20       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.